Tissue patches and associated systems and methods are described. Certain embodiments are related to inventive systems and methods in which tissue patches can be made quickly and robustly without the use of complicated fabrication or sterilization equipment. For example, in some embodiments, tissue p
Tissue patches and associated systems and methods are described. Certain embodiments are related to inventive systems and methods in which tissue patches can be made quickly and robustly without the use of complicated fabrication or sterilization equipment. For example, in some embodiments, tissue patches are made by applying a compressive force to a liquid medium comprising fibrinogen (and/or fibrin) between two surfaces (e.g., within a syringe or other chamber). A filter can be placed within or near the volume in which the compressive force is applied to the liquid medium such that unwanted material (e.g., water, blood cells, and the like) is passed through the filter while desirable components (e.g., fibrin, fibrinogen, and/or other desirable components) are retained by the filter to form the patch. In this way, the concentration of fibrin (and/or fibrinogen) within the liquid medium can be increased, potentially dramatically, as the compressive force is applied to the liquid-containing composition. In addition, in some embodiments, at least a portion of the fibrinogen and/or fibrin can chemically react (e.g., the fibrinogen can polymerize to form fibrin and/or the fibrin can cross-link) during application of the compressive force. Reaction and concentration can lead to the formation of a highly-concentrated, mechanically robust patch that can be handled relatively easily and provide good structural reinforcement at a wet site, such as a bleeding wound.
대표청구항▼
1. A kit, comprising: an unsupported solid matrix comprising fibrin at a concentration of at least about 10 grams per liter of the solid matrix, wherein the solid matrix is sterile and configured for application to a tissue surface, and the solid matrix has a tensile strength of between about 175 kP
1. A kit, comprising: an unsupported solid matrix comprising fibrin at a concentration of at least about 10 grams per liter of the solid matrix, wherein the solid matrix is sterile and configured for application to a tissue surface, and the solid matrix has a tensile strength of between about 175 kPa and about 650 kPa when measured as a true stress at break; anda primer composition comprising a water-activated polymeric adhesive. 2. The kit of claim 1, wherein the water-activated polymeric adhesive comprises a co-polymer of a vinyl ether and maleic anhydride. 3. The kit of claim 2, wherein the vinyl ether comprises an alkyl vinyl ether. 4. The kit of claim 2, wherein the vinyl ether comprises a divinyl ether. 5. The kit of claim 1, wherein the water-activated polymeric adhesive comprises one or more polymers of acrylic acid. 6. The kit of claim 5, wherein the one or more polymers of acrylic acid are cross-linked with a polyalkenyl ether and/or a divinyl alcohol. 7. The kit of claim 5, wherein the one or more polymers of acrylic acid are cross-linked with a polyalkenyl ether. 8. The kit of claim 5, wherein the one or more polymers of acrylic acid are cross-linked with a divinyl alcohol. 9. The kit of claim 1, wherein the water-activated polymeric adhesive is present within the primer composition in an amount of from about 5 wt % to about 50 wt %. 10. The kit of claim 1, wherein the primer composition further comprises a cellulose derivative. 11. The kit of claim 10, wherein the cellulose derivative is present within the primer composition in an amount of from about 1 wt % to about 40 wt %. 12. The kit of claim 1, wherein the solid matrix has an aspect ratio of at least about 5:1. 13. The kit of claim 1, wherein the solid matrix has an average thickness of between about 500 microns and about 1 cm. 14. The kit of claim 1, wherein the solid matrix has a Young's modulus of about 10 GPa or less after sterilization using gamma radiation at an intensity of 30 kGy. 15. The kit of claim 1, wherein the fibrin within the solid matrix is cross-linked to a degree such that, after submerging the solid matrix in a 6M aqueous solution of urea at 25° C., the unsupported solid matrix retains its structural integrity over a period of at least about 2 hours. 16. The kit of claim 1, wherein the fibrin within the solid matrix is cross-linked to a degree such that, after submerging the solid matrix in an 8M aqueous solution of urea at 25° C., the unsupported solid matrix retains its structural integrity over a period of at least about 2 hours.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (132)
Blomback, Birger; Hessel, Birgit; Olsson, Per; Stromberg, Lennart; Swedenborg, Jesper; Stocker, Kurt, Adhesive for the gluing of biological tissues.
Juergensen Kay (Murten CHX) Aeschlimann Daniel (Basel CHX) Hunziker Ernst B. (Riedholz CHX), Biological adhesive composition and method of promoting adhesion between tissue surfaces.
Doggett Roger H. (Natick MA) Buccigross Henry L. (Needham MA), Bonding method employing water-activatable adhesive compositions comprising a plasticizer and an N-sulfohydrocarbon-subs.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Compositions useful as fibrin sealants.
David B. Masters, Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices.
Li Lehmann K. (Fairfield CT) Warren Russell F. (Greenwich CT) Arnoczky Steven P. (New York NY) Bedard Robert J. (Southbury CT), Fibrin clot delivery device and method.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Fibrin sealant compositions.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Fibrin sealant compositions and methods for utilizing same.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Fibrin sealant compositions and methods for utilizing same.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Fibrin sealant compositions and methods for utilizing same.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Fibrin sealant compositions and methods for utilizing same.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Fibrin sealant compositions and methods for utilizing same.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Fibrin sealant compositions and methods for utilizing same.
Rothwell, Stephen W.; Krishnamurti, Chitra; Reid, III, Thomas J., Fibrinogen bandages and arterial bleeding models and methods of making and using thereof.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Kit for preparing a fibrin sealant.
Seelich,Thomas; Broermann,Ralf, Method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method.
de Maat, Monica Petronella Maria; Koolwijk, Pieter, Method for the acceleration or deceleration of angiogenesis using fibrin matrix formed from increased or decreased HMW/LMW fibrinogen ratio.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Method of making a composition comprising a fibrin monomer.
Murray Douglas G. (Willowdale CAX) Smith Dennis C. (Toronto CAX) Guillet James E. (Don Mills CAX), Method of making a hydrogel-forming wound dressing or skin coating material.
Patat Jean-Louis,FRX ; Delmas Olivier,FRX ; Schmitthaeusler Roland,FRX, Method of preparing a biological glue able to coagulate simply by addition of calcium ions.
Burgess, Willson H.; Greisler, Howard P.; Drohan, William N.; Maciag, Thomas; MacPhee, Martin J., Method of preparing a tissue sealant-treated biomedical material.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Methods and compositions using fibrin monomer to make a fibrin sealant.
McKerracher,Lisa, Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Nondynamic fibrin monomer on bandages, sutures, prostheses and dressings.
Heimburger Norbert (Marburg DEX) Fuhge Peter (Lahntal DEX) Ronneberger Hansjrg (Marburg DEX), One-component tissue adhesive and a process for the production thereof.
Antanavich Richard D. (Paso Robles CA) Dorian Randel (Orinda CA), Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant.
Heath David,GBX ; Middleton Sarah Margaret,GBX ; Harris Roy,GBX ; Church Nicola Jane,GBX, Platelet substitutes and conjugation methods suitable for their preparation.
Amery, Michael J.; Sibbons, Paul; Burnett, Stuart; Rickets, Sally-Anne; Edwardson, Peter A. D.; Hughes, Jonathan; Hollingsbee, Derek A.; Cederholm-Williams, Stewart A.; Trumbull, Horace R.; Griffin, , Prevention of post surgical adhesions using a fibrin monomer sealant.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Solid compositions of fibrin monomer.
Drohan,William N.; MacPhee,Martin J.; Burgess,Wilson H.; Nunez,Hernan; Singh,Manish; Liau,Gene; Maciag,Thomas, Supplemented and unsupplemented tissue sealants, methods of their production and use.
MacPhee,Martin J.; Drohan,William N.; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Hollinger,Jeffrey O.; Maciag,Thomas, Supplemented and unsupplemented tissue sealants, methods of their production and use.
MacPhee,Martin J.; Drohan,William N.; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Maciag,Thomas; Singh,Manish, Supplemented and unsupplemented tissue sealants, methods of their production and use.
MacPhee,Martin James; Drohan,William Nash; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Maciag,Thomas, Supplemented and unsupplemented tissue sealants, methods of their production and use.
Bass Lawrence S. (Little Neck NY) Libutti Steven K. (Fort Lee NJ) Eaton Alexander M. (Durham NC), Tissue bonding and sealing composition and method of using the same.
Bass Lawrence S. (Little Neck NY) Libutti Steven K. (Lido Beach NY) Eaton Alexander M. (New York NY), Tissue bonding and sealing composition and method of using the same.
Wadstrom Jonas (Dag Hammarskjolds vag 281 S-756 52 Uppsala SEX), Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer.
Tse Daphne C. ; Mankarious Samia S. ; Liu Shu Len ; Thomas William R. ; Alpern Melaine ; Enomoto Stanley T. ; Garanchon Cataline M., Topical fibrinogen complex.
Rivlin Jonathan B. (East Brunswick NJ) Vodoor Sam B. (Parlin NJ) Herring William A. (Appelton WI), Water activated adhesive and paper-plastic tape containing same.
Mumper, Russell; Jay, Michael, pH-sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.